Fig. 5
From: Enhancing dendritic cell immunotherapy for melanoma using a simple mathematical model
![Fig. 5](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12976-015-0007-0/MediaObjects/12976_2015_7_Fig5_HTML.gif)
Simulation of immunotherapy changing the number of DCs doses. Interval injection every 48 hours applying 106 DCs per dose during three weeks (Table 2, Protocol 10) a 85.97 % of decrease was obtained. Tumor population (thick line) and amount of DCs injected (dotted line) are shown